Preparation of Recombinant Adeno-associated Virus Carrying Heme Oxygenase-1 Gene

HE Xianghu,WANG Yanlin,WANG Chengyao,WU Xiaobing,DAI Le,LI Na
DOI: https://doi.org/10.3969/j.issn.1671-8852.2007.04.001
2007-01-01
Abstract:Objective: To construct the recombinant adeno-associated virus(AAV) vector carrying rat heme oxygenase-1(rHO-1) gene.Methods: The gene sequence coding rHO-1 was amplified from the rat spleen by RT-PCR.The fragment was cloned into a general AAV vector plasmid pSNAV to construct the recombinant vector pSNAV-rHO-1,which was verified by restriction digestion and DNA sequencing,then the recombinant pSNAV-rHO-1 was transfected into BHK-21 packaging cells by lipofectine-mediated transfection.AAV vector cells-BHK-21 carrying rHO-1 gene were then screened using G418 and called BHK/rHO-1 cells.BHK/rHO-1 cells were subsequently infected with the recombinant virus HSV1-rc/△UL2,which could express Rep and Cap,and was able to package and recombine AAV.The infected BHK-21 cells were collected and purified.The titer of the recombinant virus AAV-rHO-1 was detected by DNA dot blot.Results: The gene sequence coding rHO-1 was amplified from the rat spleen,which was identical with that of GenBank by DNA sequencing.The titer of AAV-rHO-1 was approximately 1.5×1015 v.g/L.Conclusion: The high-titer,purified viral stock of AAV-rHO-1 was successfully obtained,which can serve as the further experimental study of gene therapy of cardiovascular diseases.
What problem does this paper attempt to address?